Hydroxymethylglutaryl coenzyme A reductase inhibitors as monotherapy in the treatment of hypercholesterolemia
- 1 March 1990
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 65 (12), 19-22
- https://doi.org/10.1016/0002-9149(90)91250-a
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Clinical experience with lovastatinThe American Journal of Cardiology, 1990
- THE PHYSIOLOGICAL DISPOSITION OF LOVASTATIN1989
- Effects of simvastatin and probucol in hypercholesterolemia (simvastatin multicenter study group II)The American Journal of Cardiology, 1989
- Comparison between lovastatin and gemfibrozil in the treatment of primary hypercholesterolemia: The finnish multicenter studyThe American Journal of Cardiology, 1988
- Discovery, biochemistry and biology of lovastatinThe American Journal of Cardiology, 1988
- A Multicenter Comparison of Lovastatin and Cholestyramine Therapy for Severe Primary HypercholesterolemiaPublished by American Medical Association (AMA) ,1988
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987
- The Lipid Research Clinics Coronary Primary Prevention Trial ResultsJAMA, 1984
- Effects of probucol on low density lipoprotein removal and high density lipoprotein synthesisAtherosclerosis, 1981